Bourdiol, Alexandre
Legros, Vincent
Vardon-Bounes, Fanny
Rimmele, Thomas
Abraham, Paul
Hoffmann, Clément
Dahyot-Fizelier, Claire
Jonas, Maud
Bouju, Pierre
Cirenei, Cédric
Launey, Yoann
Le Gac, Gregoire
Boubeche, Samia
Lamarche, Edouard
Huet, Olivier
Bezu, Lucillia
Darrieussecq, Julie
Szczot, Magdalena
Delbove, Agathe
Schmitt, Johan
Lasocki, Sigismond
Auchabie, Johann
Petit, Ludivine
Kuhn-Bougouin, Emmanuelle
Asehnoune, Karim
Ingles, Hugo
Roquilly, Antoine
Cinotti, Raphaël
Yavchitz, Amélie
Sigault, Stéphanie
Mazereaud, Aurélien
Bezu, Lucilia
Léger, Maxime
Evain, Jean-Noël
,
,
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Prevalence and risk factors of significant persistent pain symptoms after critical care illness: a prospective multicentric study
https://doi.org/10.1186/s13054-023-04491-w
Article History
Received: 21 February 2023
Accepted: 15 May 2023
First Online: 25 May 2023
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations. The study was approved by an Ethics Committee (Comité pour la Protection des Personnes Sud-Est III, N° 2021–019 B). Patients received oral and written information prior to enrolment and provided informed consent to participate.
: Not applicable.
: Dr. Cinotti has received consulting fees for PAION outside the scope of the study. Dr. Roquilly reported receiving grants and consulting fees from Merck and bioMérieux outside the scope of the study. Dr. Asehnoune reported receiving lecture fees from Baxter, Fisher & Paykel, and LFB and consulting fees from Edwards Lifesciences and LFB, outside the scope of this study. The other authors do not have any conflict of interest to declare. No competing interest is to be declared regarding the present work.